603392.SH
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
SSE · Healthcare · Biotechnology · CN
CNY 23.82
+2.58%Year over year
Reported trailing growth
- Revenue
- +2.5%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- -33.1%
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +25.4%
- EBITDA
- +4462.1%
- EPS
- +1426.0%
Three-year CAGR
- Revenue
- -45.4%
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- -34.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026